Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Assets (2016 - 2025)

Abeona Therapeutics has reported Return on Assets over the past 15 years, most recently at 0.35% for Q4 2025.

  • Quarterly results put Return on Assets at 0.35% for Q4 2025, up 76.0% from a year ago — trailing twelve months through Dec 2025 was 0.35% (up 76.0% YoY), and the annual figure for FY2025 was 0.43%, up 117.0%.
  • Return on Assets for Q4 2025 was 0.35% at Abeona Therapeutics, down from 0.37% in the prior quarter.
  • Over the last five years, Return on Assets for ABEO hit a ceiling of 0.37% in Q3 2025 and a floor of 2.04% in Q3 2022.
  • Median Return on Assets over the past 5 years was 0.62% (2024), compared with a mean of 0.65%.
  • Biggest five-year swings in Return on Assets: crashed -154bps in 2022 and later surged 125bps in 2023.
  • Abeona Therapeutics' Return on Assets stood at 0.94% in 2021, then decreased by -7bps to 1.0% in 2022, then increased by 27bps to 0.73% in 2023, then skyrocketed by 43bps to 0.41% in 2024, then soared by 184bps to 0.35% in 2025.
  • The last three reported values for Return on Assets were 0.35% (Q4 2025), 0.37% (Q3 2025), and 0.37% (Q2 2025) per Business Quant data.